[geoip-content country=”US, AF, DZ, AS, AO, AI, AQ, AG, AR, AW, AU, BS, BH, BD, BB, BZ, BJ, BM, BT, BO, BQ, BW, BV, BR, IO, BN, BF, BI, KH, CM, CA, CV, KY, CF, TD, CL, CN, CX, CC, CO, KM, CG, CD, CK, CR, CU, CW, CI, DJ, DM, DO, EC, EG, SV, GQ, ER, ET, FK, FO, FJ, GF, PF, TF, GA, GM, GH, GL, GD, GP, GU, GT, GG, GN, GW, GY, HT, HM, HN, HK, IN, ID, IR, IQ, IM, IL, JM, JP, JE, JO, KE, KI, KP, KR, KW, KG, LA, LB, LS, LR, LY, MO, MG, MW, MY, MV, ML, MT, MH, MQ, MR, MU, YT, MX, FM, MN, MS, MZ, MM, NA, NR, NP, NC, NZ, NI, NE, NG, NU, NF, MP, OM, PK, PW, PS, PA, PG, PY, PE, PH, PN, PR, QA, RW, RE, BL, SH, KN, LC, MF, PM, VC, WS, ST, SA, SN, SC, SL, SG, SX, SB, SO, ZA, GS, SS, LK, SD, SR, SJ, SZ, SY, TW, TJ, TZ, TH, TL, TG, TK, TO, TT, TN, TM, TC, TV, UG, AE, UM, UY, UZ, VU, VE, VN, VG, VI, WF, EH, YE, ZM, ZW, AX”]
This educational supplement is only available in countries in Europe.
[/geoip-content]
[geoip-content not_country=”US, AF, DZ, AS, AO, AI, AQ, AG, AR, AW, AU, BS, BH, BD, BB, BZ, BJ, BM, BT, BO, BQ, BW, BV, BR, IO, BN, BF, BI, KH, CM, CA, CV, KY, CF, TD, CL, CN, CX, CC, CO, KM, CG, CD, CK, CR, CU, CW, CI, DJ, DM, DO, EC, EG, SV, GQ, ER, ET, FK, FO, FJ, GF, PF, TF, GA, GM, GH, GL, GD, GP, GU, GT, GG, GN, GW, GY, HT, HM, HN, HK, IN, ID, IR, IQ, IM, IL, JM, JP, JE, JO, KE, KI, KP, KR, KW, KG, LA, LB, LS, LR, LY, MO, MG, MW, MY, MV, ML, MT, MH, MQ, MR, MU, YT, MX, FM, MN, MS, MZ, MM, NA, NR, NP, NC, NZ, NI, NE, NG, NU, NF, MP, OM, PK, PW, PS, PA, PG, PY, PE, PH, PN, PR, QA, RW, RE, BL, SH, KN, LC, MF, PM, VC, WS, ST, SA, SN, SC, SL, SG, SX, SB, SO, ZA, GS, SS, LK, SD, SR, SJ, SZ, SY, TW, TJ, TZ, TH, TL, TG, TK, TO, TT, TN, TM, TC, TV, UG, AE, UM, UY, UZ, VU, VE, VN, VG, VI, WF, EH, YE, ZM, ZW, AX”]
This educational supplement explores the concept of “leaving nothing behind” in the treatment of the superficial femoral artery. By considering existing treatment algorithms and looking at existing and emerging technologies, the authors in this supplement explain the benefits of the “leave nothing behind” strategy.
In this supplement:
- Roberto Ferraresi: Femoropopliteal disease: The rationale of leaving nothing behind
- Marcus Treitl: Treatment algorithm: How DCB evidence changed my practice
- Stavros Spiliopoulos: From stents to drug-coated balloons: Is this the time to shift towards a “leave nothing behind” strategy?
- Konstantinos Stavroulakis: Popliteal artery: DAART vs. DCB alone
- John G Winscott and Gregory A Stanley: A tale of two legs: Putting patients ahead by leaving nothing behind
[pdfviewer width=”100%” height=”940px” beta=”true”]https://vascularnews.com/wp-content/uploads/sites/7/2017/03/Medtronic-INPACT-SFA-supplement-LOW-RES.pdf[/pdfviewer]
[/geoip-content]
